Please assess the completion status of the following clinical trial:

Trial Title: Long-term Efficacy and Safety of V0034 CR 01B Cream in Patients With Moderate-to-severe Uremic Xerosis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Patients of both sexes, of at least 18 years of age~2. Women of childbearing potential having a reliable contraceptive method~3. Patients undergoing maintenance renal dialysis (MRD), i.e. either haemodialysis or peritoneal dialysis, due to chronic renal failure~4. Patients whose xerosis is related to their renal insufficiency status (uraemic xerosis)~5. Patients suffering from xerosis with a severity score of at least two, on at least one of the five tests areas (right lower leg, left lower leg, forearm with no arterio-venous shunt, chest, dorsum of the neck)~Exclusion Criteria:~1. Patients under 18 years of age~2. Women with childbearing potential having a positive pregnancy test at baseline~3. Patients undergoing renal dialysis for another reason than chronic renal insufficiency~4. Patients whose xerosis is due to another reason than their MRD status~5. Patients suffering from mild xerosis (i.e. score less than two on all the xerotic test areas)~6. Patients with a known history of allergy to one of the ingredients contained in the test product~7. Patients with an intercurrent condition which may interfere with a good conduct or the study parameters of the study~8. Patients treated with any other emollient/moisturising topical preparation within the seven days prior to study entry~9. Patients who participated in a study within the three months prior to study entry~10. Patients who are not affiliated to health insurance~11. Patients who are not able or willing to follow the study instructions -

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- V0034CR01B (Type: EXPERIMENTAL): cream
- V0034 CR 01B vehicle (Type: PLACEBO_COMPARATOR): cream

Based on this trial design, predict the completion outcome and termination type (if applicable).